Groundbreaking Gene Therapy Restores Natural Hearing for Genetic Deafness
On this episode of Advances in Care, Erin Welsh is joined by Dr. Lawrence Lustig, chair of the Department of Otolaryngology – Head & Neck Surgery at NewYork-Presbyterian and Columbia. Dr. Lustig has spent decades working to advance various interventions to treat genetic hearing loss and after years of research his team was the first to show that gene therapies could be effective at reversing genetic hearing loss in mouse models and eventually, humans. In April 2026, the FDA approved the first ever gene therapy for genetic deafness based on the work pushed forward by Dr. Lustig.
- Otolaryngology (ENT) - PodcastFirst FDA-Approved Gene Therapy for Congenital Deafness Paves New Treatment Pathways for Hearing Loss
Decades of research led by Dr. Lawrence Lustig led to the breakthrough treatment, which delivers a working OTOF gene to the inner ear to restore natural hearing.
- Otolaryngology (ENT) - ArticleDr. Wakenda Tyler: Surgical Collaboration Enhances Soft Tissue Sarcoma Outcomes
Dr. Wakenda Tyler, chief of orthopedic oncology at NewYork-Presbyterian and Columbia, describes the unique orthoplastics model she and her team developed for soft tissue sarcoma and how it has led to an increase in limb-sparing surgeries.
- Orthopedics, Oncology (Cancer) - VideoAI Model EchoNext Receives FDA Clearance to Aid Early Detection of Structural Heart Disease
Developed at NewYork-Presbyterian and Columbia, the tool uses electrocardiogram data to determine which patients may have hidden cardiac conditions.
- Cardiology & Heart Surgery - ArticleA Novel Immune-Based Cell Therapy Improves Treatment for Metastatic Melanoma
On this episode of Advances in Care, Erin Welsh is joined by Dr. Barbara Ma, a medical oncologist at NewYork-Presbyterian who leads Cellular Therapy for Solid Tumors at Weill-Cornell Medicine.
- Oncology (Cancer) - PodcastAATS 2026: Highlights, Insights, and Lessons in Cardiothoracic Leadership
NewYork-Presbyterian cardiothoracic surgeons from Columbia and Weill Cornell Medicine discussed groundbreaking research, advanced surgical techniques, and the future of cardiothoracic care.
- Cardiology & Heart Surgery, Pediatric Cardiology (Heart) - ArticleThe Positive Impact of Electroconvulsive Therapy for Severe Psychiatric Illness
On this episode of Advances in Care, Erin Welsh is joined by Dr. Leonardo Lopez, a psychiatrist at NewYork-Presbyterian and vice chair for inpatient services in the Department of Psychiatry at Weill Cornell Medicine.
- Psychiatry, Pediatric Psychiatry - PodcastDr. Howard Fine: Cerebral Organoid Model Transforms Glioblastoma Research
Dr. Howard Fine, a neuro-oncologist at NewYork-Presbyterian and Weill Cornell Medicine, discusses how a new approach to glioblastoma research may expand treatment options and advance precision oncology.
- Neurology & Neurosurgery, Oncology (Cancer) - VideoHow a Complex Partial Liver Transplant Saved a Two-Month Old Infant
On this episode of Advances in Care, Dr. Steven Lobritto, pediatric medical director for liver transplant at NewYork-Presbyterian and Columbia, joins host Erin Welsh to tell the story of a high-risk pediatric liver transplant that he and his team performed to save the life of a two month old baby, after the center where the baby was originally treated deemed her inoperable.
- Transplant - PodcastPatient-Driven App Provides Key Data to Advance Endometriosis Research
A Columbia research project uses the principles of citizen science to better understand symptoms, causes, and management of the disease.
- Women's Health (OB/GYN) - ArticleCerebral Organoids Provide New Strategy to Personalize Glioblastoma Treatment
On this episode of Advances in Care, Erin Welsh is joined by Dr. Howard Fine, a neuro-oncologist at NewYork-Presbyterian and director of the Brain Tumor Center at Weill Cornell Medicine, to explore his pioneering research on glioblastoma, the most common and aggressive form of brain cancer.
- Neurology & Neurosurgery, Oncology (Cancer) - PodcastNewYork-Presbyterian Team Among the First in the Nation to Implant New FDA-Approved Bioprosthetic Mitral Valve
Dr. Arnar Geirsson led the surgical team, which used the new valve to treat a case of mitral valve regurgitation.
- Cardiology & Heart Surgery - ArticleNavigating High-Risk Pregnancy with Multidisciplinary Cardio-Obstetrics Care
Erin Welsh is joined by Dr. Jennifer Haythe, director of the Adult Pulmonary Hypertension Center and Cardio-Obstetrics programs at NewYork-Presbyterian and Columbia, to discuss the prevalence of high-risk pregnancies due to heart disease and the multi-disciplinary efforts required for optimal patient care.
- Cardiology & Heart Surgery, Women's Health (OB/GYN) - PodcastAI Clinician Tool Flags Pregnant Patients at Risk for Postpartum Depression
By alerting OB-GYNs to at-risk patients before PPD symptoms begin, the tool makes it easier to provide preventive care.
- Women's Health (OB/GYN), Psychiatry - ArticleRedefining Treatment for Chiari Malformation with a Transitional Care Model
On this episode of Advances in Care, Erin Welsh and Dr. Jeffrey Greenfield, pediatric neurosurgeon at NewYork-Presbyterian and director of the Chiari CARE program at Weill Cornell Medicine, discuss a rare condition called Chiari malformation.
- Neurology & Neurosurgery, Pediatric Neurology & Neurosurgery - PodcastNovel TAVR System Introduces Minimally Invasive Treatment for Aortic Regurgitation
NewYork-Presbyterian and Columbia physicians led the ALIGN-AR trial that helped validate the new FDA-approved transcatheter valve system.
- Cardiology & Heart Surgery - ArticleSingle Port Robotic Surgery Transforms Outcomes for Lung Tumor Removal
Erin Welsh is joined by Dr. Jeffrey Port, a thoracic surgeon at NewYork-Presbyterian and Weill Cornell Medicine, and a leader in thoracic surgical oncology, to discuss advances in minimally invasive robotic surgery and the unique collaborative care model that his program employs to operate on complex chest tumors.
- Cardiology & Heart Surgery - PodcastNewYork-Presbyterian Offers Innovative Approach to Treating Peritoneal Surface Malignancies
CRS-HIPEC is a two-pronged therapy that involves surgical tumor removal and heated chemotherapy administered directly to the abdominal cavity.
- Oncology (Cancer), Gastroenterology & GI Surgery - ArticleNEJM Study Proves AI-Based FFR Tool Assesses Coronary Stenosis as Well as Current Wire-Based Standard
Dr. Ajay Kirtane led the international ALL-RISE trial, which demonstrated that a novel tool that measures fractional flow reserve using angiogram images was noninferior to conventional wire-based testing.
- Cardiology & Heart Surgery - ArticleBrain Organoid Models Pave the Way for Precision Medicine for Glioblastoma
Dr. Howard Fine’s GLICO models aim to advance personalized therapies for glioblastoma using mini brains derived from patients’ stem cells.
- Oncology (Cancer), Neurology & Neurosurgery - ArticlePage1 of 38